Login |
Create New Account
sales@aaronchem.com
![]() |
Cyclo[(R)-3-phenyl-b-alanyl-L-2-aminobutanoyl-(2a,3a,4a)-3,4-dichloro-L-prolyl-L-2-aminobutanoyl-L-seryl] Cat#:AR00AU0M CAS:148057-23-2 MDL:MFCD03093766 MF:C25H33Cl2N5O6 MW:570.4654 Purity:98% |
$270.00/1mg,Global Stock $539.00/5mg,Global Stock |
View Details |
![]() |
Eptinezumab Cat#:AR00AU14 CAS:1644539-04-7 MDL:MFCD19228817 MF: MW: Purity:99% |
$185.00/1mg,Global Stock $554.00/5mg,Global Stock $939.00/10mg,Global Stock |
View Details |
![]() |
Fremanezumab Cat#:AR00AU16 CAS:1655501-53-3 MDL: MF: MW: Purity:95% |
$385.00/1mg,Global Stock $1077.00/5mg,Global Stock |
View Details |
![]() |
Galcanezumab Cat#:AR00AU17 CAS:1578199-75-3 MDL:MFCD00272728 MF: MW: Purity:98% |
$616.00/1mg,Global Stock $1539.00/5mg,Global Stock |
View Details |
![]() |
Vobarilizumab Cat#:AR00AU2Q CAS:1628814-88-9 MDL:MFCD28118985 MF: MW: Purity:97% |
$493.00/1mg,Global Stock |
View Details |
![]() |
Bicyclo[3.1.0]hexane-2,6-dicarboxylic acid, 2-amino-, (1R,2R,5S,6R)-rel- (9CI) Cat#:AR00AWL3 CAS:176027-90-0 MDL:MFCD30728441 MF: MW: Purity:97% |
$170.00/1mg,Global Stock $462.00/5mg,Global Stock $739.00/10mg,Global Stock $1185.00/25mg,Global Stock |
View Details |
![]() |
Faralimomab Cat#:AR00B1DI CAS:167816-91-3 MDL:MFCD30728441 MF: MW: Purity:95% |
$539.00/1mg,Global Stock $1400.00/5mg,Global Stock |
View Details |
![]() |
hexaaspartic acid Cat#:AR00B2G3 CAS:145224-96-0 MDL: MF:C24H32N6O19 MW:708.5397 Purity:98% |
$85.00/5mg,Global Stock $139.00/10mg,Global Stock $277.00/25mg,Global Stock $448.00/50mg,Global Stock |
View Details |
![]() |
Triperiden Cat#:AR00B59W CAS:14617-17-5 MDL:MFCD22124241 MF: MW: Purity:99% |
$154.00/50mg,Global Stock $247.00/100mg,Global Stock $739.00/500mg,Global Stock |
View Details |
![]() |
DNA,d(P-thio)(C-T-C-T-C-G-C-A-C-C-C-A-T-C-T-C-T-C-T-C-C-T-T-C-T) Cat#:AR00B9BB CAS:153021-75-1 MDL: MF:C237H310N72O131P24S24 MW:7776.3314 Purity:98% |
$308.00/1mg,Global Stock $785.00/5mg,Global Stock $1262.00/10mg,Global Stock |
View Details |
© 2019 Aaron Chemicals LLC. All Rights Reserved.